Cancer risk in microscopic colitis: a retrospective cohort study
Alexander N. Levy(Tufts Medical Center), Ashwin N. Ananthakrishnan(Harvard University), Nienke Z. Borren(Massachusetts General Hospital), Hamed Khalili(Harvard University), Kyle Staller(Massachusetts General Hospital), Daniel C. Chung(Massachusetts General Hospital), William Tan(Massachusetts General Hospital), Benjamin Maxner(University of Massachusetts Chan Medical School), Danielle Bellavance(Thomas Jefferson University)
Cited by 36
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k